AMPE - Ampio Pharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development6,828.61210,420.73210,546.28715,111.686
Selling General and Administrative4,355.355,255.4676,536.0679,055.885
Non Recurring----
Others----
Total Operating Expenses11,183.96215,676.19917,082.35424,167.571
Operating Income or Loss-11,183.962-15,676.199-17,082.354-24,167.571
Income from Continuing Operations
Total Other Income/Expenses Net45,170.128-36,326.989-2,081.27559.853
Earnings Before Interest and Taxes-11,183.962-15,676.199-17,082.354-24,167.571
Interest Expense-5.012-5.012-5.012-5.012
Income Before Tax33,986.166-51,891.945-19,163.629-24,107.718
Income Tax Expense----
Minority Interest---927.83
Net Income From Continuing Ops33,986.166-51,891.945-19,163.629-24,107.718
Non-recurring Events
Discontinued Operations----9,606.199
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income33,986.166-51,891.945-19,163.629-32,010.242
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares33,986.166-51,891.945-19,163.629-32,010.242